CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$2.09
-4.79%
Mkt Cap $466.30M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$8.50
Range $6.00 – $11.00
Implied Upside
+307.7%
Consensus $8.50 vs current $2.09
NASDAQ·Healthcare·Biotechnology
$2.09
-4.79%
Mkt Cap $466.30M
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$8.50
Range $6.00 – $11.00
+307.7%
Consensus $8.50 vs current $2.09